The digitization of data, changes to how patient data is shared, and a wealth of real-world data (RWD) mean hospitals and drug developers can form richer insights on patient populations, improve clinical trial recruitment and develop more effective treatments for chronic conditions. But challenges to accessing and interpreting this data remain. These were some of the talking points of a webinar sponsored by PurpleLab, Eliminating Blind Spots in the Patient Journey.

Webinar panelists included Steve Emrick, PurpleLab senior vice president of clinical informatics solutions and health nexus ; Russ Cobb, PurpleLab chief marketing officer; and Dr. Ben Freiberg, Principal Informatics Systems Lead with Genentech’s gCS Computational Catalysts. Genentech is part of Roche.

RWD can include data fr

See Full Page